India’s Sun Pharma has regained its financial footing but the plant in Halol, India, that was at the heart of many of its earlier issues continues to present a few nagging problems. According to the ...

MUMBAI (Reuters) - India's largest drugmaker, Sun Pharmaceutical Industries, plans to ask U.S. regulators by the middle of this year to re-inspect a plant in Gujarat after they criticised ...

After years of criticism from the FDA, Sun’s Halol plant still can’t get through an FDA inspection without the agency finding some deficiency. In June, it was just one observation, but a just ...

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai May 29, 2014. REUTERS/Danish Siddiqui/Files MUMBAI (Reuters) - Sun ...

MUMBAI – The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report ...

A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. In the letter to Mumbai-based company, the USFDA pointed out drug firm's ...

The US Food and Drug Administration (FDA) had listed Sun Pharmaceutical Industries Ltd's Halol facility in Gujarat under an import alert, the company said today. Shares of Sun Pharmaceutical ...

Sun Pharma share price: Stocks of Sun Pharmaceutical Industries Limited, NSE: SUNPHARMA traded flat in early morning deals on Friday. Check Sun Pharma share price. Pic: Reuters Sun Pharma share price: ...

Shares of Sun Pharmaceutical Industries fell as much as 4.55 per cent to hit intraday low of Rs 674 after the Bombay Stock Exchange sought clarification from Sun Pharma. Drug major Sun Pharmaceutical ...